VTRSViatris Inc.

$16B

Q4 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3.2B-0.9% YoY

Gross Profit

$1.3B40.0% margin

Operating Income

$421M13.0% margin

Net Income

$244M7.5% margin

EPS (Diluted)

$0.46

QoQ Revenue Growth

+8.4%

Cash Flow

Operating Cash Flow

$496M

Free Cash Flow

$376M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$35.8B

Total Liabilities

$22.5B

Stockholders' Equity

$13.3B

Cash & Equivalents

$292M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.2B	$3.3B	-0.9%
Gross Profit	$1.3B	$1.3B	-3.0%
Operating Income	$421M	$316M	+33.2%
Net Income	$244M	$418M	-41.5%

VTRS Q4 2017 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena